Syocin Biotech
Revolutionizing the way in which plant bacterial diseases are treated and cured to improve world food availability
Revolutionizing the way in which plant bacterial diseases are treated and cured to improve world food availability
Syocin Biotech is a biotechnology startup that aims to revolutionize the treatment and cure of plant bacterial diseases to improve global food availability. Founded in 2019, the company's focus is on developing high-precise Biobactericides using Synthetic Biology. Their bio-based products not only prioritize the health of consumers and the environment but also contribute to preventing crop loss for growers and reducing food waste.
The company recently secured a $450.00K Pre Seed Round investment on 30 December 2021. The investment was led by notable firms including Blue Horizon, GRIDX, and GISEV Family Office. With a core focus on Biotechnology and AgriTech industries, Syocin Biotech holds promise in addressing critical challenges within the agriculture sector and has gained the support of key investors in its pursuit of global impact.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $450.00K | 3 |
|
30 Dec 2021 |
| Pre Seed Round | $50.00K | 1 |
|
28 Apr 2021 |
| Pre Seed Round | $200.00K | 1 |
|
13 Dec 2019 |
No recent news or press coverage available for Syocin Biotech.
We care about your data, and we'd love to use cookies make your experience better.
